Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1956 1
1962 1
1963 1
1964 6
1965 4
1966 4
1967 5
1968 1
1969 5
1970 7
1971 3
1972 6
1973 2
1974 2
1975 2
1976 1
1977 3
1978 5
1979 4
1980 4
1981 6
1982 3
1983 6
1984 11
1985 21
1986 16
1987 17
1988 28
1989 28
1990 25
1991 20
1992 23
1993 17
1994 28
1995 13
1996 21
1997 18
1998 28
1999 22
2000 26
2001 23
2002 26
2003 26
2004 30
2005 26
2006 25
2007 18
2008 31
2009 29
2010 41
2011 41
2012 36
2013 43
2014 44
2015 52
2016 49
2017 58
2018 41
2019 61
2020 72
2021 76
2022 79
2023 52
2024 18

Text availability

Article attribute

Article type

Publication date

Search Results

1,315 results

Results by year

Filters applied: . Clear all
Page 1
Androgen insensitivity syndrome: a review.
Batista RL, Costa EMF, Rodrigues AS, Gomes NL, Faria JA Jr, Nishi MY, Arnhold IJP, Domenice S, Mendonca BB. Batista RL, et al. Among authors: nishi my. Arch Endocrinol Metab. 2018 Mar-Apr;62(2):227-235. doi: 10.20945/2359-3997000000031. Arch Endocrinol Metab. 2018. PMID: 29768628 Free PMC article. Review.
Neuroblastoma.
Nakagawara A, Li Y, Izumi H, Muramori K, Inada H, Nishi M. Nakagawara A, et al. Among authors: nishi m. Jpn J Clin Oncol. 2018 Mar 1;48(3):214-241. doi: 10.1093/jjco/hyx176. Jpn J Clin Oncol. 2018. PMID: 29378002 Review.
Prevalence of disease-causing genes in Japanese patients with BRCA1/2-wildtype hereditary breast and ovarian cancer syndrome.
Kaneyasu T, Mori S, Yamauchi H, Ohsumi S, Ohno S, Aoki D, Baba S, Kawano J, Miki Y, Matsumoto N, Nagasaki M, Yoshida R, Akashi-Tanaka S, Iwase T, Kitagawa D, Masuda K, Hirasawa A, Arai M, Takei J, Ide Y, Gotoh O, Yaguchi N, Nishi M, Kaneko K, Matsuyama Y, Okawa M, Suzuki M, Nezu A, Yokoyama S, Amino S, Inuzuka M, Noda T, Nakamura S. Kaneyasu T, et al. Among authors: nishi m. NPJ Breast Cancer. 2020 Jun 12;6:25. doi: 10.1038/s41523-020-0163-1. eCollection 2020. NPJ Breast Cancer. 2020. PMID: 32566746 Free PMC article.
Crystal structure of N-(1H-indol-2-yl-methyl-idene)-4-meth-oxy-aniline.
Taneda M, Nishi M, Kubono K, Kashiwagi Y, Matsumoto T. Taneda M, et al. Among authors: nishi m. Acta Crystallogr E Crystallogr Commun. 2022 Mar 31;78(Pt 4):449-452. doi: 10.1107/S2056989022002973. eCollection 2022 Apr 1. Acta Crystallogr E Crystallogr Commun. 2022. PMID: 35492277 Free PMC article.
Application of iNKT Cell-targeted Active Immunotherapy in Cancer Treatment.
Yamashita K, Arimoto A, Nishi M, Tanaka T, Fujita M, Fukuoka E, Sugita Y, Nakagawa A, Hasegawa H, Suzuki S, Kakeji Y. Yamashita K, et al. Among authors: nishi m. Anticancer Res. 2018 Jul;38(7):4233-4239. doi: 10.21873/anticanres.12719. Anticancer Res. 2018. PMID: 29970556 Review.
1,315 results